Takashi Kishimoto

Nessuna posizione attualmente

66 anni

Health Technology

Consumer Services

Profilo

Takashi Kei Kishimoto worked as a Senior Director-Inflammation Research at Millennium Pharmaceuticals, Inc. from 1999 to 2006.
He then worked as an Associate Director-Research at Boehringer Ingelheim Corp.
before becoming the Vice President-Discovery Research at Momenta Pharmaceuticals, Inc. from 2006 to 2011.
He then became the Chief Scientific Officer at Selecta Biosciences, Inc. in 2011, where he worked until 2023.
He also worked as a Vice President-Research at Momenta Corp.
Dr. Kishimoto holds a doctorate degree from Harvard University and an undergraduate degree from New College of Florida.

Precedenti posizioni note di Takashi Kishimoto

Società	Posizione	Fine
CARTESIAN THERAPEUTICS, INC.	Direttore Tecnico/Scientifico/R&S	13/11/2023
MOMENTA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/06/2011
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment	Corporate Officer/Principal	01/01/2006
Momenta Corp.	Direttore Tecnico/Scientifico/R&S	-
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products	Direttore Tecnico/Scientifico/R&S	-

Vedi nel dettaglio l'esperienza di Takashi Kishimoto

Formazione di Takashi Kishimoto

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Takashi Kishimoto

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	7
Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment	Health Technology
Momenta Pharmaceuticals, Inc. Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases	Health Technology
Selecta Biosciences, Inc. Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases	Health Technology
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New College of Florida New College of Florida Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products	Health Technology
Momenta Corp.